1dmk: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1dmk" size="450" color="white" frame="true" align="right" spinBox="true" caption="1dmk, resolution 1.90Å" /> '''BOVINE ENDOTHELIAL N...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1dmk.gif|left|200px]]<br /><applet load="1dmk" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1dmk.gif|left|200px]]<br /><applet load="1dmk" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1dmk, resolution 1.90&Aring;" />
caption="1dmk, resolution 1.90&Aring;" />
'''BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 4-AMINO-6-PHENYL-TETRAHYDROPTERIDINE'''<br />
'''BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 4-AMINO-6-PHENYL-TETRAHYDROPTERIDINE'''<br />


==Overview==
==Overview==
Pathological nitric oxide (NO) generation in sepsis, inflammation, and, stroke may be therapeutically controlled by inhibiting NO synthases (NOS)., Here we targeted the (6R)-5,6,7,8-tetrahydro-l-biopterin (H(4)Bip)-binding, site of NOS, which, upon cofactor binding, maximally increases enzyme, activity and NO production from substrate l-arginine. The first generation, of H(4)Bip-based NOS inhibitors employed a 4-amino pharmacophore of, H(4)Bip analogous to antifolates such as methotrexate. We developed a, novel series of 4-oxo-pteridine derivatives that were screened for, inhibition against neuronal NOS (NOS-I) and a structure-activity, relationship was determined. To understand the structural basis for pterin, antagonism, selected derivatives were docked into the NOS pterin binding, cavity. Using a reduced 4-oxo-pteridine scaffold, derivatives with certain, modifications such as electron-rich aromatic phenyl or benzoyl groups at, the 5- and 6-positions, were discovered to markedly inhibit NOS-I, possibly due to hydrophobic and electrostatic interactions with Phe(462), and Ser(104), respectively, within the pterin binding pocket. One of the, most effective 4-oxo compounds and, for comparisons an active 4-amino, derivative, were then co-crystallized with the endothelial NOS (NOS-III), oxygenase domain and this structure solved to confirm the hypothetical, binding modes. Collectively, these findings suggest (i) that, unlike the, antifolate principle, the 4-amino substituent is not essential for, developing pterin-based NOS inhibitors and (ii), provide a steric and, electrostatic basis for their rational design.
Pathological nitric oxide (NO) generation in sepsis, inflammation, and stroke may be therapeutically controlled by inhibiting NO synthases (NOS). Here we targeted the (6R)-5,6,7,8-tetrahydro-l-biopterin (H(4)Bip)-binding site of NOS, which, upon cofactor binding, maximally increases enzyme activity and NO production from substrate l-arginine. The first generation of H(4)Bip-based NOS inhibitors employed a 4-amino pharmacophore of H(4)Bip analogous to antifolates such as methotrexate. We developed a novel series of 4-oxo-pteridine derivatives that were screened for inhibition against neuronal NOS (NOS-I) and a structure-activity relationship was determined. To understand the structural basis for pterin antagonism, selected derivatives were docked into the NOS pterin binding cavity. Using a reduced 4-oxo-pteridine scaffold, derivatives with certain modifications such as electron-rich aromatic phenyl or benzoyl groups at the 5- and 6-positions, were discovered to markedly inhibit NOS-I, possibly due to hydrophobic and electrostatic interactions with Phe(462) and Ser(104), respectively, within the pterin binding pocket. One of the most effective 4-oxo compounds and, for comparisons an active 4-amino derivative, were then co-crystallized with the endothelial NOS (NOS-III) oxygenase domain and this structure solved to confirm the hypothetical binding modes. Collectively, these findings suggest (i) that, unlike the antifolate principle, the 4-amino substituent is not essential for developing pterin-based NOS inhibitors and (ii), provide a steric and electrostatic basis for their rational design.


==About this Structure==
==About this Structure==
1DMK is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with ACT, CAC, ZN, HEM, AP6 and ITU as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1DMK OCA].  
1DMK is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with <scene name='pdbligand=ACT:'>ACT</scene>, <scene name='pdbligand=CAC:'>CAC</scene>, <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=HEM:'>HEM</scene>, <scene name='pdbligand=AP6:'>AP6</scene> and <scene name='pdbligand=ITU:'>ITU</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DMK OCA].  


==Reference==
==Reference==
Line 16: Line 16:
[[Category: Al-Masoudi, N.]]
[[Category: Al-Masoudi, N.]]
[[Category: Berg, M.]]
[[Category: Berg, M.]]
[[Category: Frohlich, L.G.]]
[[Category: Frohlich, L G.]]
[[Category: Gerwig, R.]]
[[Category: Gerwig, R.]]
[[Category: Groehn, V.]]
[[Category: Groehn, V.]]
Line 23: Line 23:
[[Category: Li, H.]]
[[Category: Li, H.]]
[[Category: Martasek, P.]]
[[Category: Martasek, P.]]
[[Category: Masters, B.S.]]
[[Category: Masters, B S.]]
[[Category: Matter, H.]]
[[Category: Matter, H.]]
[[Category: Mohr, D.]]
[[Category: Mohr, D.]]
Line 29: Line 29:
[[Category: Pfleiderer, W.]]
[[Category: Pfleiderer, W.]]
[[Category: Poulos, T.]]
[[Category: Poulos, T.]]
[[Category: Raman, C.S.]]
[[Category: Raman, C S.]]
[[Category: Schmidt, H.H.]]
[[Category: Schmidt, H H.]]
[[Category: Schnabel, J.]]
[[Category: Schnabel, J.]]
[[Category: Strobel, H.]]
[[Category: Strobel, H.]]
Line 42: Line 42:
[[Category: alpha-beta fold]]
[[Category: alpha-beta fold]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 13:24:50 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:18:11 2008''